WATSON 415 Pill - orange round
Pill with imprint WATSON 415 is Orange, Round and has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.
Estropipate is used in the treatment of Hypoestrogenism; Atrophic Vaginitis; Oophorectomy; Osteoporosis; Postmenopausal Symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 415
Estropipate
- Imprint
- WATSON 415
- Strength
- 1.5 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Estrogens
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 52544-0415 (Discontinued)
More about estropipate
- Check interactions
- Compare alternatives
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogens
- En español
Patient resources
Other brands
Ogen 1.25, Ogen 2.5, Ortho-Est
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
